Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Source: nct - Country: Sweden,Australia,Germany,France,Spain,United Kingdom,Austria,Russian Federation,Italy,Norway
nct
Update Il y a 5 ans
Predictive Markers in GHD and TS Children Treated With SAIZEN®
The study aims at identifying the predictive markers after one month of Saizen therapy in Growth Hormone Deficiency (GHD) and Turner Syndrome children. The study will recruit approximately 360 children in several countries worldwide. The study lasts for about the first one month of daily growth hormone treatment. There will be three clinic visits during the month of the study. There is an initial visit, then a visit before growth hormone treatment starts and finally a visit at the fourth week of treatment. The study requires two additional blood tests to a regular Saizen treatment follow-up. One sample is taken before growth hormone injections start and one additional blood sample is taken at the fourth week of treatment.
Country
Argentina
,
Australia
,
Austria
,
Canada
,
France
,
Germany
,
Italy
,
Norway
,
Russian Federation
,
Singapore
,
Spain
,
Sweden
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
1